Author: Yen, Wei-Chen; Wu, Yi-Hsuan; Wu, Chih-Ching; Lin, Hsin-Ru; Stern, Arnold; Chen, Shih-Hsiang; Shu, Jwu-Ching; Tsun-Yee Chiu, Daniel
Title: Impaired inflammasome activation and bacterial clearance in G6PD deficiency due to defective NOX/p38 MAPK/AP-1 redox signaling Document date: 2019_11_2
ID: 6fw4thkq_51
Snippet: Certain chronic and infectious diseases are associated with G6PD deficiency [13, 24, 43] . The impact of G6PD status on innate immunity, especially upon inflammasome activation, is unknown. The present study is the first to show that G6PD-kd THP-1 cells and PBMCs from patients with G6PD deficiency with different mutations of the enzyme have a decrease in IL-1β expression and NLRP3 inflammasome (E) c-Fos quantitative level of (D). β-Actin was us.....
Document: Certain chronic and infectious diseases are associated with G6PD deficiency [13, 24, 43] . The impact of G6PD status on innate immunity, especially upon inflammasome activation, is unknown. The present study is the first to show that G6PD-kd THP-1 cells and PBMCs from patients with G6PD deficiency with different mutations of the enzyme have a decrease in IL-1β expression and NLRP3 inflammasome (E) c-Fos quantitative level of (D). β-Actin was used as a normalized loading control in (A) and (D). The results are representative of three independent experiments (n = 3, *p < 0.05). (F) Western blot of cytoplasmic and nuclear proteins. Cells were treated with LPS for 60 min. α-Tubulin and lamin B1 were used as cytoplasmic and nuclear loading controls. (G) c-Fos quantitative level of (F). The results are representative of three independent experiments (n = 3, *p < 0.05). (H) Luciferase activity assay of 293T cells transfected with a firefly luciferase reporter plasmid containing a partial sequence with the putative AP-1 binding site (WT) or the deleted mutation (AP1D). This assay was standardized by Renilla activity after transfection for 48 h (*p < 0.05 compared to basal conditions).
Search related documents:
Co phrase search for related documents- inflammasome activation and present study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- innate immunity and luciferase reporter: 1, 2, 3, 4, 5, 6
- innate immunity and present study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58
- innate immunity and quantitative level: 1
- innate immunity and western blot: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- loading control and luciferase reporter: 1, 2
- loading control and present study: 1
- loading control and Renilla activity: 1
- loading control and western blot: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
- LPS treat and luciferase reporter: 1
- luciferase reporter and present study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33
- luciferase reporter and quantitative level: 1, 2
- luciferase reporter and Renilla activity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- luciferase reporter and western blot: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55
- nuclear cytoplasmic protein and present study: 1
- nuclear cytoplasmic protein and western blot: 1, 2
- nuclear cytoplasmic protein western blot and western blot: 1
- partial sequence and present study: 1, 2, 3, 4, 5, 6
- partial sequence and western blot: 1
Co phrase search for related documents, hyperlinks ordered by date